NextFin News - Ares Management’s credit platform is still pulling in capital, but the latest signal from the business is not about fundraising. It is about stress. The firm’s opportunistic credit strategy is designed to lend to healthy, stressed and distressed companies, and that positioning matters because rising problem loans often reveal themselves first in portfolios built to absorb risk rather than avoid it. The key question is whether the latest uptick in weak credits is a temporary turn in the cycle or the start of a more durable repricing of private credit.
What The Signal Says About Credit Quality
The basic mechanics are straightforward. When borrowers stop paying cash interest, the affected loans move to non-accrual status, and the lender no longer books them as current income-producing assets. In private credit, that has immediate consequences for distributable income, but the broader issue is structural rather than mechanical. A non-accrual is usually a late-stage signal, not an early one. By the time it appears, the borrower has already moved from routine operating pressure into a phase where amendments, extensions or restructuring discussions are usually under way.
That is why the current discussion around Ares matters even without a precise fund-by-fund stress table. Ares reported in its second-quarter 2025 results that AUM, fee-paying AUM and management fees all grew by 24% or more year over year, while GAAP net income attributable to the company reached $137.1 million and after-tax realized income per share was $1.03. Those figures show a franchise that remains commercially strong. They do not answer the harder question: how much borrower strain is now building inside the credit books that generated those fees and profits.
The concern is not isolated to one company. Ares’ opportunistic credit business is built around flexible capital for businesses that need it, and that model thrives when market dislocation creates yield opportunities. It is less comfortable when dislocation becomes persistent enough that flexibility turns into repeated extensions and payment relief. In that setting, the lender can still report growth in AUM and fee income while the underlying asset quality quietly worsens.
The reason investors focus so much on non-accruals is that the metric compresses a great deal of information into a single signal. It captures borrower health, underwriting quality, exit conditions and the willingness of lenders to carry positions while waiting for a recovery. A rising non-accrual count does not automatically mean losses will accelerate. But it does mean the portfolio is moving closer to a point where cash yield alone no longer tells the full story.
That tension is especially important in private credit because the asset class has been sold on consistency: higher coupons, floating-rate protection and reduced volatility relative to public markets. But floating-rate income cuts both ways. As policy rates rose, many borrowers saw their debt costs reset higher while revenue growth slowed. The result is a classic late-cycle squeeze. What looked like a stable yield stream can start to look more fragile once refinancing windows narrow and operating margins absorb the rate shock.
Ares has also shown that it can raise large pools of capital through the cycle. In the second quarter of 2024, the firm said it raised $26 billion in capital. That is an impressive number and a reminder that investor demand for private-market income remains strong. Yet strong fundraising can coexist with deteriorating credit performance. In fact, that combination is often how cycles end: capital remains abundant even as the weakest credits start to crack.
The practical takeaway is that investors should read the current stress signal as a credit-quality issue first and a franchise issue second. Ares is not suddenly becoming a weaker platform because one loan book is showing more pressure. But if non-accruals keep climbing across multiple vintages and strategies, the market will start to ask whether the industry’s underwriting assumptions were built for a lower-rate world that no longer exists.
Why The Current Stress Still Looks Cyclical
The strongest reading today is still cyclical. Private credit has been moving through a higher-for-longer rate environment, and the most obvious consequence of that regime is pressure on borrowers with thinner interest coverage. When base rates rise, coupons reset upward, cash flow cushions get thinner, and companies that once looked manageable on a low-rate basis can suddenly require amendments or payment relief. That mechanism is cyclical because it is tied to the rate path and the refinancing cycle, not to a permanent change in the underlying usefulness of private credit.
There is also a historical pattern behind that view. Credit stress tends to surface after tightening cycles, not before them. The sequence is familiar: policy rates move up, refinancing becomes more expensive, weaker borrowers begin missing coverage targets, and lenders respond with restructuring rather than immediate write-downs. Non-accruals often rise only after those earlier steps fail to stabilize the borrower. That means the metric is lagging, but it is still useful because it shows where the cycle has already done damage.
Three features support the cyclical call. First, Ares still describes its opportunistic credit business as a flexible capital provider to healthy, stressed and distressed companies, which means a certain amount of borrower strain is built into the model. Second, the broader private-credit market has benefited from years of investor demand, so a little stress after such a long expansion is not a regime break by itself. Third, the company’s recent earnings history still shows a strong franchise with double-digit growth in key metrics in 2025, which argues against a sudden collapse in funding or underwriting discipline.
But the story does not stop at the cycle. The second-order issue is that private credit has grown so large that a cyclical stress wave can have quasi-structural consequences. If enough portfolios experience rising non-accruals at the same time, the market can shift from treating private credit as an income trade to treating it as a credit-risk trade. That changes how new capital is priced, how quickly borrowers can refinance and how much flexibility lenders can offer without damaging returns.
That is the real mechanism to watch. Stress does not need to be permanent to change behavior. It only needs to be persistent enough to alter underwriting standards, sponsor expectations and the cost of refinancing. In that sense, the non-accrual uptick is a warning that the asset class may be entering a more discriminating phase even if the current wave of weak credits eventually eases.
“We seek to provide healthy, stressed and distressed companies with flexible capital.”
The quote captures the paradox. Flexibility is the product, but flexibility is also what lets the cycle linger. Lenders can extend, amend and restructure long after a borrower’s problems become visible. That can preserve value in individual cases. It can also delay the moment when the market recognizes a broader deterioration in credit quality. The longer that delay lasts, the more likely a cyclical problem begins to look structural to investors.
What Would Change The Thesis
The best counter-thesis is that the rise in non-accruals is a mark of discipline rather than distress. In that reading, Ares is surfacing weak names early, carrying them conservatively and keeping the platform resilient while competitors with looser underwriting hide problems for longer. If that is true, the current uptick is not a warning about the franchise. It is evidence that the firm is taking its own credit stress seriously before it becomes a larger loss problem.
That view is plausible and important. Private credit cannot be judged only by the number of non-accruals in a single quarter because the asset class is intentionally active in stressed situations. The right question is whether the rise in non-accruals is contained, temporary and manageable, or whether it keeps broadening across vintages and strategies. If it stabilizes while fee income stays firm, the current concern will look like a normal cycle. If it keeps climbing, the market will begin to price a longer period of pressure.
The signal that would falsify the cyclical thesis is quantifiable: if non-accruals continue to rise over the next two reporting periods while realized income and fee-paying AUM fail to stabilize, the story stops being about a short-term credit wobble and becomes one about a more persistent reset in private-credit underwriting. Conversely, if the measure flattens as refinancing conditions improve, the current pressure will look more like the late stage of a rate shock than the beginning of a structural break.
Short term, the exposed names are borrowers with weak cash flow, small buffers and expensive refinancing needs. Medium term, the question is whether lenders can recycle capital without reaching for weaker credits to keep returns up. Long term, the asset class is unlikely to disappear; private credit has too much demand and too much institutional support for that. But the market may become less willing to treat every yield premium as if it were free.
Ares remains a major beneficiary of investor appetite for private-market income, and the firm’s scale still gives it room to absorb individual problem credits. The risk is not that one fund turns bad overnight. The risk is that a string of small non-accruals teaches the market a bigger lesson: in private credit, flexibility can delay losses, but it cannot repeal them.
Explore more exclusive insights at nextfin.ai.
